BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 23, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Alize Pharma raises funds to advance AZP-531
June 7, 2012
Long-term study of Contrave begins enrollment
June 7, 2012
U.S. team presents new products for cancer and other disorders
June 7, 2012
Phase III elagolix study begins in endometriosis
June 6, 2012
CHMP schedules hearing for Vivus' Qnexa MAA
June 6, 2012
Janssen files NDA for canagliflozin
June 5, 2012
Takeda expands its position in gout market
June 5, 2012
Mitsubishi Tanabe terminates license agreement
June 4, 2012
Roche group identifies new cathepsin inhibitors
June 4, 2012
U.S. team patents new DAP kinase 1 inhibitors and PPAR-gamma/GPR120 partial agonists
June 1, 2012
Previous
1
2
…
563
564
565
566
567
568
569
570
571
…
1800
1801
Next
RSS